Model DetailsEye - Harderian gland neoplasm
Model Name |
Eye - Harderian gland neoplasm | Strain |
(C57BL/6N x C3H/HeN)F1 |
Tumor Inducing Agent(s) |
Diet : calorie restricted |
Tumor Synonym |
Harderian gland neoplasm |
Strain Synonyms |
BCF1 • B6C3F1 • C57BL/6NxC3H/HeN F1 • B6C3F1 • (C57BL/6N X C3H/HeN)F1 |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Eye - Harderian gland | Female |
4.8% (2 of 42 mice) |
12-24 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
6.7% (1 of 15 mice) |
30 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
6.7% (1 of 15 mice) |
36 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
0% (0 of 22 mice) |
42-48 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
4.3% (4 of 94 mice) |
12-48 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
0% (0 of 7 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
0% (0 of 20 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
2.9% (1 of 34 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
7.3% (4 of 55 mice) |
42-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
4.3% (5 of 116 mice) |
12-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
0% (0 of 3 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
0% (0 of 3 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
20% (3 of 15 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
2.9% (1 of 34 mice) |
42-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
7.3% (4 of 55 mice) |
12-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Female |
4.9% (13 of 265 mice) |
12-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
0% (0 of 42 mice) |
12-24 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
0% (0 of 15 mice) |
30 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
0% (0 of 15 mice) |
36 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
6.25% (2 of 32 mice) |
42-48 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
1.9% (2 of 104 mice) |
12-48 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
0% (0 of 3 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
11.1% (1 of 9 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
10% (2 of 20 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
8.6% (6 of 70 mice) |
42-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
8.8% (9 of 102 mice) |
12-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
0% (0 of 4 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
0% (0 of 3 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
23.1% (3 of 13 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
8.3% (3 of 36 mice) |
42-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
10.7% (6 of 56 mice) |
12-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Eye - Harderian gland | Male |
6.5% (17 of 262 mice) |
12-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |